Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 8 | 6 | 5 | — | 1 | 15 |
Castration-resistant prostatic neoplasms | D064129 | — | — | 4 | 2 | 2 | — | — | 6 |
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | — | 1 |
Drug common name | Aglatimagene besadenovec |
INN | aglatimagene besadenovec |
Description | Aglatimagene besadenovec is a gene pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Gene |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL3544993 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 5Z72SSS34W (ChemIDplus, GSRS) |